Royal Bank of Canada’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-17,856
| Closed | -$424K | – | 7859 |
|
|
2023
Q3 | $424K | Buy |
17,856
+9,037
| +102% | +$170K | ﹤0.01% | 4193 |
|
|
2023
Q2 | $142K | Sell |
8,819
-11,017
| -56% | -$183K | ﹤0.01% | 5055 |
|
|
2023
Q1 | $346K | Sell |
19,836
-5,227
| -21% | -$94K | ﹤0.01% | 4178 |
|
|
2022
Q4 | $471K | Buy |
25,063
+13,345
| +114% | +$257K | ﹤0.01% | 4163 |
|
|
2022
Q3 | $207K | Sell |
11,718
-55,382
| -83% | -$961K | ﹤0.01% | 4747 |
|
|
2022
Q2 | $1.17M | Buy |
67,100
+44,700
| +200% | +$852K | ﹤0.01% | 3354 |
|
|
2022
Q1 | $469K | Buy |
22,400
+12,728
| +132% | +$244K | ﹤0.01% | 4333 |
|
|
2021
Q4 | $172K | Buy |
9,672
+2,135
| +28% | +$34.3K | ﹤0.01% | 5480 |
|
|
2021
Q3 | $106K | Buy |
7,537
+1,920
| +34% | +$29.9K | ﹤0.01% | 5659 |
|
|
2021
Q2 | $93K | Buy |
5,617
+3,833
| +215% | +$68.7K | ﹤0.01% | 5659 |
|
|
2021
Q1 | $32K | Sell |
1,784
-20,828
| -92% | -$411K | ﹤0.01% | 6174 |
|
|
2020
Q4 | $412K | Buy |
22,612
+251
| +1% | +$3.98K | ﹤0.01% | 4301 |
|
|
2020
Q3 | $285K | Buy |
22,361
+2,475
| +12% | +$31.6K | ﹤0.01% | 4294 |
|
|
2020
Q2 | $218K | Sell |
19,886
-28
| -0.1% | -$290 | ﹤0.01% | 4399 |
|
|
2020
Q1 | $208K | Buy |
19,914
+12,646
| +174% | +$163K | ﹤0.01% | 4309 |
|
|
2019
Q4 | $117K | Buy |
7,268
+5,813
| +400% | +$96K | ﹤0.01% | 5004 |
|
|
2019
Q3 | $23K | Buy |
1,455
+800
| +122% | +$13.3K | ﹤0.01% | 5455 |
|
|
2019
Q2 | $13K | Buy |
655
+506
| +340% | +$9.45K | ﹤0.01% | 5942 |
|
|
2019
Q1 | $3K | Buy |
149
+11
| +8% | +$191 | ﹤0.01% | 6464 |
|
|
2018
Q4 | $2K | Sell |
138
-1,813
| -93% | -$31.1K | ﹤0.01% | 6491 |
|
|
2018
Q3 | $39K | Buy |
1,951
+801
| +70% | +$17K | ﹤0.01% | 5361 |
|
|
2018
Q2 | $22K | Buy |
1,150
+485
| +73% | +$7.67K | ﹤0.01% | 5504 |
|
|
2018
Q1 | $9K | Sell |
665
-889
| -57% | -$11.7K | ﹤0.01% | 5767 |
|
|
2017
Q4 | $21K | Sell |
1,554
-3,945
| -72% | -$56.7K | ﹤0.01% | 5584 |
|
|
2017
Q3 | $86K | Buy |
5,499
+4,063
| +283% | +$65.6K | ﹤0.01% | 5117 |
|
|
2017
Q2 | $24K | Sell |
1,436
-944
| -40% | -$14.3K | ﹤0.01% | 5471 |
|
|
2017
Q1 | $36K | Sell |
2,380
-1,427
| -37% | -$21K | ﹤0.01% | 5327 |
|
|
2016
Q4 | $50K | Sell |
3,807
-591
| -13% | -$7.57K | ﹤0.01% | 5259 |
|
|
2016
Q3 | $51K | Sell |
4,398
-1,089
| -20% | -$13.1K | ﹤0.01% | 5150 |
|
|
2016
Q2 | $66K | Sell |
5,487
-39,343
| -88% | -$529K | ﹤0.01% | 4986 |
|
|
2016
Q1 | $683K | Sell |
44,830
-6,991
| -13% | -$106K | ﹤0.01% | 3388 |
|
|
2015
Q4 | $836K | Buy |
51,821
+46,933
| +960% | +$685K | ﹤0.01% | 3273 |
|
|
2015
Q3 | $61K | Buy |
4,888
+395
| +9% | +$5.42K | ﹤0.01% | 5036 |
|
|
2015
Q2 | $74K | Sell |
4,493
-6,093
| -58% | -$98.2K | ﹤0.01% | 5004 |
|
|
2015
Q1 | $169K | Sell |
10,586
-2,658
| -20% | -$44K | ﹤0.01% | 4328 |
|
|
2014
Q4 | $207K | Buy |
13,244
+1,109
| +9% | +$16.2K | ﹤0.01% | 4313 |
|
|
2014
Q3 | $167K | Sell |
12,135
-2,970
| -20% | -$45.1K | ﹤0.01% | 4306 |
|
|
2014
Q2 | $242K | Buy |
15,105
+4,242
| +39% | +$67.1K | ﹤0.01% | 4033 |
|
|
2014
Q1 | $183K | Sell |
10,863
-11,448
| -51% | -$208K | ﹤0.01% | 4179 |
|
|
2013
Q4 | $469K | Buy |
22,311
+9,071
| +69% | +$204K | ﹤0.01% | 3473 |
|
|
2013
Q3 | $288K | Sell |
13,240
-195
| -1% | -$4.16K | ﹤0.01% | 3818 |
|
|
2013
Q2 | $251K | Buy |
+13,435
| New | +$245K | ﹤0.01% | 3715 |
|
Other funds holding NXGN
Royal Bank of Canada's NXGN Position: Q4 2023 in Review
Royal Bank of Canada sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 17,856 shares — an estimated $424K sold.
Royal Bank of Canada first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $1.17M in Q2 2022. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Royal Bank of Canada reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Royal Bank of Canada sold 17,856 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $424K.
- Royal Bank of Canada first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
- Royal Bank of Canada's NextGen Healthcare, Inc. Common Stock position peaked at $1.17M in Q2 2022.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.